GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » Notes Receivable

Hybio Pharmaceutical Co (SZSE:300199) Notes Receivable : ¥0.0 Mil (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co Notes Receivable?

Hybio Pharmaceutical Co's Notes Receivable for the quarter that ended in Mar. 2025 was ¥0.0 Mil.


Hybio Pharmaceutical Co Notes Receivable Historical Data

The historical data trend for Hybio Pharmaceutical Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hybio Pharmaceutical Co Notes Receivable Chart

Hybio Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hybio Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hybio Pharmaceutical Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Hybio Pharmaceutical Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Hybio Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057
Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.
Executives
Ceng Shao Gui Director
Ceng Shao Bin Director
Ceng Shao Qiang Director
Zhu Wen Feng Directors, Directors, and Executives
Tao An Jin Executives
Wei Hong Executives
Yuan Jian Cheng Directors, executives
Liu Jian Executives
Yang Jun Executives
Executives
Zhu Ning Supervisors
Yang Chun Hai Supervisors
Cai Lei Directors, executives

Hybio Pharmaceutical Co Headlines

No Headlines